Philip Spanheimer
@PSpanheimer
Followers
554
Following
1K
Media
27
Statuses
256
Surgeon-Scientist @UNC | Training: Iowa Surgery, MSKCC | Clinic: Breast Cancer, Sarcoma | NCI-funded Lab: molecular genetics, targeted therapeutics.
Joined October 2018
Superb UNC-Duke Surg Onc journal club on Gastric/GEJ cancers. Excellent discussion and presentations by @SocSurgOnc 1st & 2nd yr CGSO Fellows! So much to learn from these talented superstars! @DukeSurgOnc @UNCSurgery @YehlabUNC @PSpanheimer @globalsurgallie @michael_lidsky
1
6
15
Outstanding presidential address Dr. Ron Weigal at the American Surgical Association annual meeting!
0
8
45
NIH funding creates medicines, jobs, and economic growth
27
169
392
I study breast cancer in large part because of my time @UIowa_Surgery in the Weigel lab. Well deserved honor for a truly exceptional mentor.
One of the perks of being Society of University Surgeons @UnivSurg President is the honor of announcing the SUS Lifetime Achievement Award winner, the highest honor in our organization. Please join me in congratulating the 2024 SUS LTAA winner - Dr. Ron Weigel @UIowa_Surgery .
2
1
16
While it’s very rare, male breast cancer can be more challenging to treat and has poorer outcomes compared to breast cancer in women. As we close out #MensHealthMonth, we highlight BCRF investigator Dr. Jose Pablo Leone, who seeks to address this. https://t.co/tQlcYEBf1g
bcrf.org
Dr. Jose Pablo Leone discusses breakthroughs in treating male breast cancer. Learn about clinical trials and new therapies. Support innovative research now!
1
10
21
Tremendously grateful to @PSpanheimer @Dr_X_25 @kimhjUNC and our collaborators at @UNC_Lineberger @UNCSurgery for making this possible. Thank you for letting me join the team!
0
1
4
Had a lot of fun operating with @Dr_X_25 on his last day @UNCSurgery. @MSKCancerCenter - he’s ready for you. @MichaelDAngeli2 @KevinCSoaresMD @JoshSmithMDPhD @SDownsCanner
1
5
54
We are thrilled to announce that @KellyHerremans has matched @UNCSurgery as our 2025 incoming #CGSO Fellow! Proud of you and looking forward to a bright future! @UFSurgery @JoseTrevinoMD @CapriceGreenber @SocSurgOnc @PSpanheimer @YehlabUNC @kimhjUNC @RunLiz @UNC_Lineberger
0
7
30
Look out for UNC resident Selena An! She gave a beautiful oral presentation at #SSO2024 @PSpanheimer @UNCSurgery @SocSurgOnc
0
2
24
2
3
44
Please join us @SocSurgOnc #SSO2024 in Atlanta on Thursday at noon to learn more about our amazing fellowship in Breast Surgical Oncology! @MSKCancerCenter @ASBrS. You might even meet some of our current amazing fellows! @GinaMatar @krpawloski @juliamchandler
0
9
34
Why do some patients with #breastcancer respond to treatment and some do not? Philip Spanheimer, MD and collaborators advance depth of exploration in how breast tumors become resistant to therapy: https://t.co/0pnUXa3RaG
@PSpanheimer | @UNC_Lineberger | @UNC_SOM
0
6
22
It’s finally out! @PNASNews
https://t.co/QOBssjIRju
@tarekmzikry @scwolff305 @JoleneRanek @stallaertlab @purvislab
@UNCSurgery @UNC_lineberger @CompMedUNC
pnas.org
The CDK4/6 inhibitor palbociclib blocks cell cycle progression in Estrogen receptor–positive, human epidermal growth factor 2 receptor–negative (ER...
5
4
29
Engaging patients in translational cancer research. @paspears88 @UNCBreastSPORE @UNC_Lineberger @UNCSurgery
https://t.co/k0Hx0NEd0k
healthtalk.unchealthcare.org
UNC researchers are partnering with patient advocates on an innovative program.
0
1
10
Fantastic grand rounds yesterday by @Dr_X_25 on immunotherapy in cancer from work in @SDownsCanner lab. Soon-to-be @MSKCancerCenter fellow. It’s been fun watching your progress so far! @UNCSurgery @CapriceGreenber @kimhjUNC @jigdeneve @Dr_KGallagher @RunLiz @LarryTKim @dgerber6
1
4
30
New paper: Most approved drug combinations for advanced cancer (1995-2020) have predictable clinical efficacy, because they have additive effect on Progression-Free Survival times. In @NatureCancer at https://t.co/Z7xabVpouT by @HaeunHwangbo @SC_Patterson @PlanaDeborah 1/6
10
143
469
Great work @kchen315 !
We developed an AI model which can use intra-op specimen mammography to predict the pathologic margin status of partial mastectomy specimens with accuracy equal to surgeons and radiologists. @Dr_KGallagher @shawnmgomez
https://t.co/rY02054J7r
0
0
5
Newly published in @CCR_AACR
https://t.co/Pt4v06HicI Funding: @UNCBreastSPORE @UnivSurg @theNCI
@UNCSurgery @UNC_Lineberger @TheHectorFranco @sugarciare @RashaKakati @CalhounBC_Path
pubmed.ncbi.nlm.nih.gov
This novel ex vivo model system now provides the foundation to define responsive and resistant subpopulations within heterogeneous human tumors, which can be used to develop precise single cell-based...
NEW PREPRINT: https://t.co/w1YXIUaodE Intratumor heterogeneity is associated with worse outcomes and poor response to treatment across human solid organ tumors - so can we measure distinct responses in distinct cell types? Is that informative?
2
5
22
So proud of @graypeery9. Asked a question in clinic, designed a study and saw it through to publication. Does your scribe do that????? @UNC_SOM 👀 out for her application!! @Dr_KGallagher @UNC_Lineberger @UNCSurgery @lauraburkbauer
https://t.co/ChdTqtQGIc
0
5
25
Our review on advances in the management of Early-Stage Triple-Negative Breast Cancer #bcsm @UNC_Lineberger
@prarthnavb @PSpanheimer @brunklab
Happy to share our review article on advances in early stage triple negative breast cancer @IJMS_MDPI. A wonderful collaboration with my @ASCO mentor extraordinaire @YAbdouMD and colleagues. #bcsm #tnbc
https://t.co/In4SmCZxXe
0
10
19